800-799-2234
Office Locations
Mon - Fri 09:00 am - 05:00 pm
West Virginia's #1
Mesothelioma Law Firm
We Have Won
Thousands of Cases
Trusted By
10,000+ Clients
Immediate Assistance 24/7

Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53

Condition: Solid Tumor NCT Number: NCT03975387 Estimated Enrollment: 191 Phases: Phase 1|Phase 2 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: ASTX295-01 Study First Received: June 5, 2019 Last Updated: October 5, 2021...
Read More
Condition: Metastatic Cancer|Solid Tumor NCT Number: NCT04672434 Estimated Enrollment: 100 Phases: Phase 1 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: Sym024-01 Study First Received: December 17, 2020 Last Updated: July 2, 2021...
Read More
Condition: Advanced/Metastatic Solid Tumor NCT Number: NCT05047536 Estimated Enrollment: 225 Phases: Phase 1 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: KZR-261-101 Study First Received: September 17, 2021 Last Updated: October 15, 2021...
Read More
Condition: Solid Tumor NCT Number: NCT04794699 Estimated Enrollment: 40 Phases: Phase 1 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: IDE397-001 Study First Received: March 12, 2021 Last Updated: October 29, 2021 Estimated...
Read More
Condition: Acinar Cell Carcinoma|Adenoid Cystic Carcinoma|Adrenal Cortex Carcinoma|Adrenal Gland Pheochromocytoma|Anal Canal Neuroendocrine Carcinoma|Anal Canal Undifferentiated Carcinoma|Angiosarcoma|Apocrine Neoplasm|Appendix Mucinous Adenocarcinoma|Bartholin Gland Transitional Cell Carcinoma|Basal Cell Carcinoma|Bladder Adenocarcinoma|Breast Metaplastic Carcinoma|Cervical Adenocarcinoma|Cholangiocarcinoma|Chordoma|Colorectal Squamous Cell Carcinoma|Desmoid Fibromatosis|Endometrial Transitional Cell Carcinoma|Endometrioid Adenocarcinoma|Esophageal Neuroendocrine Carcinoma|Esophageal Undifferentiated Carcinoma|Extrahepatic Bile Duct Carcinoma|Extramammary Paget Disease|Fallopian Tube Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Fibromyxoid Tumor|Gallbladder Carcinoma|Gastric Neuroendocrine...
Read More
Condition: Solid Tumors|Malignant Pleural Mesothelioma|Gastric Adenocarcinoma|Colorectal Adenocarcinoma|Sarcoma|Pancreatic Adenocarcinoma|Ewing Sarcoma|Chondrosarcoma NCT Number: NCT03715933 Estimated Enrollment: 172 Phases: Phase 1 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: Ph1 INBRX-109 Study First Received: October 23,...
Read More
Condition: Pancreatic Cancer|Thyroid Cancer|Lung Cancer|Esophageal Cancer|Thymus Cancer|Colon Cancer|Rectal Cancer|GIST|Anal Cancer|Bile Duct Cancer|Duodenal Cancer|Gallbladder Cancer|Gastric Cancer|Liver Cancer|Small Intestine Cancer|Peritoneal Surface Malignancies|Familial Adenomatous Polyposis|Lynch Syndrome|Bladder Cancer|Kidney Cancer|Penile Cancer|Prostate Cancer|Testicular Cancer|Ureter Cancer|Urethral Cancer|Hypopharyngeal Cancer|Laryngeal Cancer|Lip Cancer|Oral Cavity Cancer|Nasopharyngeal Cancer|Oropharyngeal Cancer|Paranasal Sinus Cancer|Nasal Cavity Cancer|Salivary Gland Cancer|Skin Cancer|CNS Tumor|CNS Cancer|Mesothelioma|Breast Cancer|Leukemia|Melanoma|Sarcoma|Unknown Primary Tumor|Multiple Myeloma|Ovarian Cancer|Endometrial Cancer|Vaginal Cancer|Neuroendocrine Tumors|Plasma Cell...
Read More
Condition: Advanced Cancer|Anal Carcinoma|Anal Cancer|Biliary Cancer|Cholangiocarcinoma|Bile Duct Cancer|Neuroendocrine Tumor|Carcinoid Tumor|Endometrial Carcinoma|Endometrial Cancer|Cervical Carcinoma|Cervical Cancer|Vulvar Carcinoma|Vulvar Cancer|Small Cell Lung Carcinoma|Small Cell Lung Cancer (SCLC)|Mesothelioma|Thyroid Carcinoma|Thyroid Cancer|Salivary Gland Carcinoma|Salivary Gland Cancer|Salivary Cancer|Parotid Gland Cancer|Advanced Solid Tumors|Colorectal Carcinoma NCT Number: NCT02628067 Estimated Enrollment: 1595 Phases: Phase 2 Age Group: 18 Years and older   (Adult, Older Adult) Gender:...
Read More
Condition: Advanced Solid Tumor|Diffuse Large B Cell Lymphoma|Lymphoma, T-Cell|Mesothelioma, Malignant|Prostatic Neoplasms, Castration-Resistant NCT Number: NCT04104776 Estimated Enrollment: 268 Phases: Phase 1|Phase 2 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: 0209-01 Study First...
Read More
Condition: Advanced Bile Duct Carcinoma|Advanced Breast Carcinoma|Advanced Cervical Carcinoma|Advanced Endometrial Carcinoma|Advanced Esophageal Carcinoma|Advanced Gastric Carcinoma|Advanced Head and Neck Carcinoma|Advanced Lung Non-Small Cell Carcinoma|Advanced Lung Small Cell Carcinoma|Advanced Malignant Solid Neoplasm|Advanced Ovarian Carcinoma|Advanced Penile Carcinoma|Advanced Pleural Malignant Mesothelioma|Advanced Urothelial Carcinoma|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer...
Read More
1 2 3 8
Call Now ButtonCALL NOW